Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Progressive jaundice, rapid unexplained weight loss, a new mass, gastrointestinal bleeding, fever, persistent vomiting or a substantial change in pain requires urgent re-imaging and specialist review for pancreatic cancer, obstruction, pseudocyst, infection or bleeding rather than automatic attribution to chronic pancreatitis.
Synopsis
Diagnose irreversible pancreatic disease, treat pain without stigma, replace exocrine function, detect type 3c diabetes and malnutrition, and select duct or cancer pathways safely.
Chronic pancreatitis is progressive fibro-inflammatory pancreatic damage causing recurrent or persistent upper-abdominal pain, ductal or calcific structural change and eventual exocrine or endocrine failure.
Do not assume alcohol causation because a person drinks: smoking, genetic variants, autoimmune disease, recurrent acute episodes, obstruction, anatomical factors and metabolic disease require consideration.
CT demonstrates calcification, atrophy, duct dilatation, stones, pseudocyst and mass; MRI/MRCP and EUS help when early or ductal disease remains uncertain and the result would change care.
Key red flags
Cancer or acute complication
Progressive jaundice, rapid unexplained weight loss, a new mass, gastrointestinal bleeding, fever, persistent vomiting or substantially altered pain requires urgent re-imaging and specialist review.
Investigation priorities
01
Pancreatic-protocol contrast CTFirst step
Assess calcification, atrophy, duct enlargement, stones, inflammatory mass, pseudocyst, obstruction and possible malignancy.
Management branches
NutritionExocrine replacement plan
Symptoms, nutritional decline or testing supports pancreatic exocrine insufficiency.
Refer to a pancreatic-experienced dietitian and document stool, intake, weight, muscle, alcohol, smoking, vitamins and alternative malabsorption diagnoses.
Start an available enteric-coated pancreatin product with all meals and snacks, teaching the person to spread the prescribed amount through eating.
Key medicines
Enteric-coated pancreatin replacementPrescribe an individual lipase-based amount with every meal and snack, spread through eating and titrated using current BNF and specialist guidance.
Proton-pump inhibitor adjunctUse a standard current BNF adult regimen as a specialist-informed trial when adequate correctly timed pancreatin remains clinically ineffective.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.